Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Anesthesia, Essays and Researches|October 12, 2019
Efficacy of Adding Midazolam to Bupivacaine for Transversus Abdominis Plane Block on Postoperative Analgesia after Hysterectomy: A Randomized Controlled StudySamah El Kenany, Mohamed Eslam Elshehawi, Ahmed Mohamed Farid, et al.
Journal of Clinical Pharmacology|August 27, 2019
Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure-Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to TofacitinibMohamed-Eslam F Mohamed, Denise Beck, Heidi S Camp, et al.
Clinical Pharmacology and Therapeutics|August 2, 2017
Use of Early Clinical Trial Data to Support Thorough QT Study Waiver for Upadacitinib and Utility of Food Effect to Demonstrate ECG Assay SensitivityMohamed-Eslam F Mohamed, Jiewei Zeng, Ping Jiang, et al.
Journal of Clinical Pharmacology|December 1, 2018
The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female SubjectsMohamed-Eslam F Mohamed, Sheryl Trueman, Tian Feng, et al.
Clinical and Translational Science|August 31, 2021
Upadacitinib pharmacokinetics and exposure-response analyses of efficacy and safety in psoriatic arthritis patients - Analyses of phase III clinical trialsElena Muensterman, Benjamin Engelhardt, Sathej Gopalakrishnan, et al.
Clinical and Translational Science|November 20, 2023
Upadacitinib: Mechanism of action, clinical, and translational scienceMohamed-Eslam F Mohamed, Sumit Bhatnagar, Julie M Parmentier, et al.
Journal of Clinical Pharmacology|November 9, 2019
Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical TrialsAhmed Nader, Sven Stodtmann, Anna Friedel, et al.
Journal of Orthopaedics and Traumatology : Official Journal of the Italian Society of Orthopaedics and Traumatology|August 17, 2023
Are the outcomes of single-stage open reduction and Dega osteotomy the same when treating DDH in patients younger than 8 years old? A prospective cohort studyAboBakr Zein, Ahmed A Khalifa, Mohamed Eslam Elsherif, et al.
British Journal of Clinical Pharmacology|May 16, 2017
Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinibMohamed-Eslam F Mohamed, Steven Jungerwirth, Armen Asatryan, et al.
Journal of Clinical Pharmacology|August 6, 2019
Effects of Upadacitinib Coadministration on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates: A Study With the Modified Cooperstown 5+1 CocktailMohamed-Eslam F Mohamed, Tian Feng, Jeffrey V Enejosa, et al.
Pageof 8